83457-101 : Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution
NDC: | 83457-101 |
Labeler: | Cordavis Limited |
Product Type: | Human Prescription Drug |
Drug Name: | Hyrimoz |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761071 |
Rev. Date: |
NDC Package Codes:
- 83457-101-01: 2 SYRINGE, GLASS IN 1 CARTON (83457‑101‑01) / .4 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Adalimumab
Dosage Strength:
- 40 mg/.4mL
Pharmaceutical Classes:
- Antibodies
- Monoclonal [CS]
- Tumor Necrosis Factor Blocker [EPC]
- Tumor Necrosis Factor Receptor Blocking Activity [MoA]
Related Products:
Based on records with the same trade name.- 83457-100 Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution by Cordavis Limited
- 83457-102 Hyrimoz 40 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited
- 83457-103 Hyrimoz 40 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited
- 83457-107 Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited
- 83457-108 Hyrimoz 20 mg/.2ml Subcutaneous Injection, Solution by Cordavis Limited
- 83457-112 HyrimozHyrimoz Kit by Cordavis Limited
- 83457-113 Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited
- 61314-454 Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution by Sandoz Inc
- 61314-473 Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution by Sandoz Inc
- 61314-476 Hyrimoz 20 mg/.2ml Subcutaneous Injection, Solution by Sandoz Inc
- 61314-509 Hyrimoz 10 mg/.1ml Subcutaneous Injection, Solution by Sandoz Inc
- 61314-517 HyrimozHyrimoz Kit by Sandoz Inc
- 61314-531 HyrimozHyrimoz Kit by Sandoz Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 83457-100Next: 83457-102 >
Related Discussions:
Humira (adalimumab) for pain
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.